[1]
N. Erdogar, “Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma”, annalsmedres, vol. 29, no. 3, pp. 198–202, Mar. 2022.